Kindred to Gentiva: Don’t Acquire Amedisys

In the latest move of Kindred Healthcare’s ongoing quest to buy Gentiva Health Services, Kindred (NYSE:KND) has sent a letter to the Gentiva (NASDAQ:GTIV) board of directors, telling the company to reconsider its pursuits of acquiring Amedisys Inc. (NASDAQ:AMED). The acquisition, Kindred writes, would disenfranchise Gentiva shareholders. Instead, Kindred urges the board to discuss its “highly […]

Amedisys Proposes Settlement Resolving Insider Trading Suit

A proposed settlement resolving a civil lawsuit accusing home health and hospice company Amedisys, Inc. (NASDAQ:AMED) of insider trading has been preliminarily approved by the United States District Court for the Middle District of Louisiana. Shareholders filed a federal lawsuit, Robert F. Bach, et al., v Amedisys, Inc., et all., against Amedisys alleging that some of […]

Managed Care Shift Will Halve Home Health Revenues for Amedisys from Humana

Home health and hospice care provider Amedisys, Inc. (NASDAQ:AMED) will see a diminished annual revenue after signing a new agreement with Humana Inc. (NYSE:HUM) regarding how it will be reimbursed for home health services provided. Under the new agreement, which reflects a national shift toward managed care, Amedisys will be paid on a per-visit basis. […]